Dr. Wen Cheng, MD

Dr. Cheng practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Cheng's NPI, 1073597043, was assigned on December 2, 2005. Dr. Cheng graduated from The Johns Hopkins University School of Medicine in 1984. Dr. Cheng holds California license A51926.

Dr. Cheng's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Cheng's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Cheng to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheng practices. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Dr. Cheng's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Dr. Cheng is board certified in thoracic and cardiac surgery by the American Board of Thoracic Surgery. Dmand AI has Dr. Cheng's licenses on file in 3 states: California, Maryland and Pennsylvania.

Dmand AI lists heart valve surgery among the conditions Dr. Cheng treats.

CMS data shows 1,268 Medicare services from Dr. Cheng across 7 procedure codes in 2024, for 884 Medicare patients. Medicare paid $536,187 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 884 Medicare patients who saw Dr. Cheng in 2024. The largest group is 75 to 84, with 363 patients. 75% of them have heart failure, and 75% have high blood pressure. 29% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheng's median patient age at 78, with 43% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Cheng for performance year 2024, reported as part of a group. Dr. Cheng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cheng as offering telehealth.

Dmand AI links 8 papers to Dr. Cheng, published from 2014 to 2025. 2016 was the busiest year, with 3. The most frequent topics are Polymorphism, Single Nucleotide and Stroke. Dr. Cheng has published most often in J Atheroscler Thromb. Dr. Cheng's most frequent co-authors are Raj R. Makkar, MD, Tarun Chakravarty, MD and Mamoo Nakamura, MD.

Dmand AI links Dr. Cheng to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Tricuspid Valve Insufficiency and Gastroesophageal Reflux.

CMS Open Payments shows 94 general payments to Dr. Cheng from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Edwards Lifesciences Corporation paid the most, $2,576.

Dmand AI lists 1 award for Dr. Cheng.

Dr. Cheng graduated from The Johns Hopkins University School of Medicine in 1984.

Dr. Cheng is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.